|
1) McLachlan SM, Nagayama Y, Rapoport B. Insight into Graves' hyperthyroidism from animal models. Endocr Rev. 2005; 26: 800-32
|
|
|
|
2) 永山雄二. Basedow病の動物モデル作成-TSH受容体抗原免疫法. 最新医学. 2003; 58: 1638-42
|
|
|
|
|
3) 永山雄二. バセドウ病動物モデルの開発と展開. 最新医学. 別冊新しい診断と治療のABC(25). 2004; 79 -87
|
|
|
|
|
|
4) 永山雄二. バセドウ病モデル動物. 日本臨床 増刊 臨床分子内分泌学3—甲状腺・副甲状腺・骨内分泌代謝系—. 2005; 63: 62-5
|
|
|
|
|
|
5) 永山雄二. モデル動物からのアプローチ. 日本臨牀. 2006; 64: 2215-8
|
|
|
|
|
|
6) Chen C-R, Abbud R, Wang C, et al. Gene expression profiles differ markedly in mouse strains that are (or are not) susceptible to hyperthyroidism induced using thyrotropin receptor-expressing adenovirus. Thyroid. 2005; 15: 1229-37
|
|
|
|
|
|
7) Aliesky HA, Pichurin PN, Chen C-R, et al. Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice. Endocrinology. 2006; 147: 2789-800
|
|
|
|
|
|
8) Seetharamaiah GS, Land KJ. Differential susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism. Thyroid. 2006; 16: 651-8
|
|
|
|
|
|
9) Pichurin P, Pichurina O, Marians RC, et al. Thyrotropin receptor knockout mice: studies on immunological tolerance to a major thyroid autoantigen. Endocrinology. 2004; 145: 1294- 301
|
|
|
|
|
|
10) Pichurin PN, Chen C-R, Chazenbalk GD, et al. Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization. J Immunol. 2006; 176: 668-76
|
|
|
|
|
|
11) Akkaraju S, Ho WY, Leoong D, et al. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity. 1997; 7: 255-71
|
|
|
|
|
|
12) Liston A, Gray DHD, Lesage S, et al. Gene dosage-limiting role of aire in thymic expression, clonal deletion and organ-specific autoimmunity. J Exp Med. 2004; 200: 1015-26
|
|
|
|
|
|
13) McLachlan SM, Pichurin PN, Nagayama Y, et al. Tolerance, regulatory T cells and autoimmunity to the thyrotropin receptor: insight from transgenic mice expressing the human TSHR A-subunit in the thyroid. Abstract in the annual meeting of the 77th American Thyroid Association. 2006
|
|
|
|
|
|
14) Sakaguchi S. Naturally arising Foxp3-expressing CD4＋CD25＋ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005; 6: 345-52
|
|
|
|
|
|
15) Rifa'i M, Kawamoto Y, Nakashima I, et al. Essential roles of CD8＋CD122＋ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med. 2004; 200: 1123-34
|
|
|
|
|
|
16) Saitoh O, Nagayama Y. Regulation of Graves'hyperthyroidism with naturally occurring CD4＋CD25＋ regulatory T cells in a mouse model. Endocrinology. 2006; 147: 2417-22
|
|
|
|
|
|
17) Saitoh O, Abiru N, Nakahara M, et al. CD8＋ CD122＋ T cells, a newly identified regulatory T cells, negatively regulate Graves' disease in a murine model. Endocrinology. In press
|
|
|
|
|
|
18) Nagayama Y, Niwa M, McLachlan SM, et al. Schistosoma mansoni and α-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves' hyperthyroidism. J Immunol. 2004; 173: 2167-73
|
|
|
|
|
|
19) Wei WZ, Jacob JB, Zielinski JF, et al. Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4＋CD25＋ regulatory T cell-depleted mice. Cancer Res. 2005; 65: 8471-8
|
|
|
|
|
|
20) Nagayama Y, Saitoh O. CD4＋CD25＋ naturally occurring regulatory T cells and not lymphopenic proliferation play a role in the pathogenesis of experimental autoimmune thyroiditis in NOD-H2h4 mice. J Autoimmun. 2007; 29: 195-202
|
|
|
|
|
|
21) Aschenbrenner K, D'Cruz LM, Vollmann EH, et al. Selection of Foxp3＋ regulatory T cells specific for self antigen expressed and presented by Aire＋ medullary thymic epithelial cells. Nat Immunol. 2007; 8: 351-8
|
|
|
|
|
|
22) Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med. 1999; 189: 877-82
|
|
|
|
|
|
23) Lenzner C, Morgenthaler NG. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease. Thyroid. 2003; 13: 1153-61
|
|
|
|
|
|
24) Gilbert JA, Kalled SL, Moorhead J, et al. Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology. 2006; 147: 4561-8
|
|
|
|
|
|
25) Kaneda T, Honda A, Hakozaki A, et al. An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice. Endocrinology. 2007; 148: 2335-44
|
|
|
|
|